Stifel Maintains Buy on Oruka Therapeutics, Raises Price Target to $72
Stifel analyst Alex Thompson maintains Oruka Therapeutics (NASDAQ:ORKA) with a Buy and raises the price target from $47 to $72.
Login to comment